SORRENTINO, SABATO
 Distribuzione geografica
Continente #
NA - Nord America 1.615
AS - Asia 1.279
EU - Europa 514
SA - Sud America 215
AF - Africa 33
OC - Oceania 1
Totale 3.657
Nazione #
US - Stati Uniti d'America 1.558
SG - Singapore 594
CN - Cina 308
IT - Italia 201
BR - Brasile 172
IN - India 115
VN - Vietnam 108
DE - Germania 67
HK - Hong Kong 48
GB - Regno Unito 46
NL - Olanda 46
SE - Svezia 44
FI - Finlandia 36
CA - Canada 28
MX - Messico 20
IQ - Iraq 18
ZA - Sudafrica 14
BD - Bangladesh 13
AR - Argentina 12
FR - Francia 12
AT - Austria 9
PL - Polonia 9
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
PK - Pakistan 8
JP - Giappone 7
TR - Turchia 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
ES - Italia 5
JO - Giordania 5
RU - Federazione Russa 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BH - Bahrain 3
DZ - Algeria 3
ET - Etiopia 3
LT - Lituania 3
TN - Tunisia 3
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
HN - Honduras 2
IE - Irlanda 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MN - Mongolia 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
Totale 3.657
Città #
San Jose 405
Singapore 249
Ashburn 215
Santa Clara 111
Chandler 103
Bengaluru 95
Hefei 93
Dallas 86
Beijing 54
Milan 53
Hong Kong 47
Munich 44
Ho Chi Minh City 37
Lawrence 36
Princeton 36
Chicago 34
London 26
New York 23
Helsinki 22
Hanoi 21
São Paulo 21
Wilmington 21
Los Angeles 18
Amsterdam 17
Turku 14
Catanzaro 12
Brooklyn 11
Rome 11
Assago 10
Boardman 10
Chennai 10
Ottawa 10
Atlanta 9
Haiphong 9
Johannesburg 9
Mexico City 9
Baghdad 8
Orem 8
San Francisco 8
Shanghai 8
Stockholm 8
Des Moines 7
Redmond 6
Tashkent 6
Warsaw 6
Brescia 5
Hanover 5
Manchester 5
Montreal 5
Nuremberg 5
Tokyo 5
Brasília 4
Buffalo 4
Cape Town 4
Charlotte 4
Council Bluffs 4
Da Nang 4
Denver 4
Erbil 4
Huntington 4
Jakarta 4
Macaé 4
Madison 4
Nairobi 4
Naples 4
Olomouc 4
Orangeburg 4
Rio de Janeiro 4
Sorocaba 4
Addis Ababa 3
Amman 3
Ankara 3
Augusta 3
Baku 3
Bari 3
Biên Hòa 3
Boston 3
Campinas 3
Cosenza 3
Ferrara 3
Guangzhou 3
Jeddah 3
Kuala Lumpur 3
Lahore 3
Montevideo 3
Ninh Bình 3
Porto Alegre 3
Portofino 3
Quito 3
Redwood City 3
São José dos Campos 3
The Dalles 3
Thái Nguyên 3
Topeka 3
Uberaba 3
Agawam 2
Bangkok 2
Barbacena 2
Berazategui 2
Bocale 2
Totale 2.246
Nome #
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 85
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 72
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 67
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 65
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 62
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 62
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 61
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 59
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 58
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 58
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 58
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 57
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 55
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 53
Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale. A Systematic review and meta-analysis. 52
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 52
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 52
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 51
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 51
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 50
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 50
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 49
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 49
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 49
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 48
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 47
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 46
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 45
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 45
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 45
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 44
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 44
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 44
Direct Oral Anticoagulants in Patients With Active Cancer 44
Non-invasive myocardial work is reduced during transient acute coronary occlusion 44
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 43
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 42
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 42
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 42
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 40
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 40
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 39
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 38
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 38
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 37
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 37
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 36
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 35
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 35
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 35
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 35
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 33
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 33
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 32
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 32
The link between anemia and adverse outcomes in patients with acute coronary syndrome 31
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 31
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 31
Cerebral Embolic Protection During TAVR 30
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 30
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 30
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 30
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis 30
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 30
Stent Thrombosis After Percutaneous Coronary Intervention 29
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 29
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 28
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 28
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 27
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 27
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 26
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 26
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 26
Effect of Transcatheter Aortic Valve Implantation on Non-Invasive Myocardial Work Parameters: A Systematic Review and Meta-Analysis 26
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 26
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 26
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 25
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 25
Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers 25
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 24
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 23
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 23
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 23
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 23
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 23
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 23
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 22
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 22
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 22
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 22
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 22
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 21
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 20
Paravalvular Leak 19
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 19
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry 18
Clinical Outcomes in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 18
Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 17
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 17
Drug-coated balloons and hybrid strategies versus drug-eluting stents in chronic total occlusions: a systematic review and meta-analysis 17
Totale 3.727
Categoria #
all - tutte 32.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 3 2 6
2021/2022120 0 0 3 29 11 4 0 28 12 13 17 3
2022/2023358 78 12 40 12 45 28 3 26 54 21 30 9
2023/2024233 28 22 12 12 3 42 0 13 64 5 18 14
2024/2025839 100 35 34 22 60 137 43 16 80 17 117 178
2025/20262.185 99 242 161 287 299 108 316 135 334 204 0 0
Totale 3.847